| |
| |
|
| Insider
Information: |
Grainger David J |
| Relationship: |
Chief Innovation Officer |
| City: |
Cheshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
962,790 |
|
|
Indirect Shares
|
27,500 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
990,290 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Centessa Pharmaceuticals Plc |
CNTA |
Chief Innovation Officer |
2023-12-31 |
962,790 |
2023-12-31 |
27,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2023-12-31 |
4 |
D |
$7.96 |
$37,412 |
D/D |
(4,700) |
962,790 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2023-09-30 |
4 |
D |
$6.47 |
$30,409 |
D/D |
(4,700) |
967,490 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2023-06-30 |
4 |
D |
$5.90 |
$25,311 |
D/D |
(4,290) |
972,190 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
77,200 |
981,305 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-12-31 |
4 |
D |
$3.10 |
$7,741 |
D/D |
(2,497) |
911,259 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-10-03 |
4 |
S |
$3.95 |
$11,270 |
D/D |
(2,853) |
908,575 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-09-30 |
4 |
D |
$4.25 |
$30,405 |
D/D |
(7,154) |
906,602 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-09-30 |
4 |
S |
$4.07 |
$9,469 |
D/D |
(2,328) |
911,428 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
913,756 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation Officer |
• – – |
2022-01-28 |
4 |
B |
$9.05 |
$248,754 |
I/I |
27,500 |
27,500 |
1.99 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Innovation OfficerOffice |
• – – |
2021-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
813,756 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
